FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225483617> ?p ?o ?g. }

• W4225483617 endingPage "e0267102" @default.
• W4225483617 startingPage "e0267102" @default.
• W4225483617 abstract "Understanding antibody responses after natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can guide the coronavirus disease 2019 (COVID-19) vaccine schedule, especially in resource-limited settings. This study aimed to assess the dynamics of SARS-CoV-2 antibodies, including anti-spike protein 1 (S1) immunoglobulin (Ig)G, anti-receptor-binding domain (RBD) total Ig, anti-S1 IgA, and neutralizing antibody against wild-type SARS-CoV-2 over time in a cohort of patients who were previously infected with the wild-type SARS-CoV-2. Between March and May 2020, 531 individuals with virologically confirmed cases of wild-type SARS-CoV-2 infection were enrolled in our immunological study. Blood samples were collected at 3-, 6-, 9-, and 12-months post symptom onset or detection of SARS-CoV-2 by RT-PCR (in asymptomatic individuals). The neutralizing titers against SARS-CoV-2 were detected in 95.2%, 86.7%, 85.0%, and 85.4% of recovered COVID-19 patients at 3, 6, 9, and 12 months after symptom onset, respectively. The seropositivity rate of anti-S1 IgG, anti-RBD total Ig, anti-S1 IgA, and neutralizing titers remained at 68.6%, 89.6%, 77.1%, and 85.4%, respectively, at 12 months after symptom onset. We observed a high level of correlation between neutralizing and SARS-CoV-2 spike protein-specific antibody titers. The half-life of neutralizing titers was estimated at 100.7 days (95% confidence interval = 44.5-327.4 days, R2 = 0.106). These results support that the decline in serum antibody levels over time in both participants with severe disease and mild disease were depended on the symptom severity, and the individuals with high IgG antibody titers experienced a significantly longer persistence of SARS-CoV-2-specific antibody responses than those with lower titers." @default.
• W4225483617 created "2022-05-05" @default.
• W4225483617 creator A5002287966 @default.
• W4225483617 creator A5006031285 @default.
• W4225483617 creator A5006890215 @default.
• W4225483617 creator A5007003740 @default.
• W4225483617 creator A5026707377 @default.
• W4225483617 creator A5027042022 @default.
• W4225483617 creator A5027750644 @default.
• W4225483617 creator A5028987829 @default.
• W4225483617 creator A5035447212 @default.
• W4225483617 creator A5042228931 @default.
• W4225483617 creator A5042282160 @default.
• W4225483617 creator A5051156541 @default.
• W4225483617 creator A5054146321 @default.
• W4225483617 creator A5054468311 @default.
• W4225483617 creator A5056827410 @default.
• W4225483617 creator A5060775751 @default.
• W4225483617 creator A5063173860 @default.
• W4225483617 creator A5067511913 @default.
• W4225483617 creator A5081787897 @default.
• W4225483617 creator A5082135516 @default.
• W4225483617 creator A5084305363 @default.
• W4225483617 creator A5084864470 @default.
• W4225483617 creator A5089975415 @default.
• W4225483617 date "2022-04-21" @default.
• W4225483617 modified "2023-09-26" @default.
• W4225483617 title "Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients" @default.
• W4225483617 cites W1936220503 @default.
• W4225483617 cites W1961523492 @default.
• W4225483617 cites W2015896540 @default.
• W4225483617 cites W2036610647 @default.
• W4225483617 cites W3001118548 @default.
• W4225483617 cites W3012756997 @default.
• W4225483617 cites W3012846954 @default.
• W4225483617 cites W3013893137 @default.
• W4225483617 cites W3013985547 @default.
• W4225483617 cites W3014721277 @default.
• W4225483617 cites W3014853902 @default.
• W4225483617 cites W3015546310 @default.
• W4225483617 cites W3015988827 @default.
• W4225483617 cites W3016445969 @default.
• W4225483617 cites W3016722972 @default.
• W4225483617 cites W3016900702 @default.
• W4225483617 cites W3017576620 @default.
• W4225483617 cites W3018517500 @default.
• W4225483617 cites W3023996322 @default.
• W4225483617 cites W3025594285 @default.
• W4225483617 cites W3034173374 @default.
• W4225483617 cites W3034425032 @default.
• W4225483617 cites W3038435002 @default.
• W4225483617 cites W3042383115 @default.
• W4225483617 cites W3042833857 @default.
• W4225483617 cites W3045296132 @default.
• W4225483617 cites W3047501982 @default.
• W4225483617 cites W3080476071 @default.
• W4225483617 cites W3082342835 @default.
• W4225483617 cites W3087542972 @default.
• W4225483617 cites W3092301564 @default.
• W4225483617 cites W3094968263 @default.
• W4225483617 cites W3096243826 @default.
• W4225483617 cites W3097439296 @default.
• W4225483617 cites W3101205394 @default.
• W4225483617 cites W3111255098 @default.
• W4225483617 cites W3111424223 @default.
• W4225483617 cites W3112389805 @default.
• W4225483617 cites W3121008609 @default.
• W4225483617 cites W3121906900 @default.
• W4225483617 cites W3125155750 @default.
• W4225483617 cites W3129633728 @default.
• W4225483617 cites W3129690878 @default.
• W4225483617 cites W3131938123 @default.
• W4225483617 cites W3178789045 @default.
• W4225483617 cites W3179238217 @default.
• W4225483617 cites W3182429467 @default.
• W4225483617 cites W3201348706 @default.
• W4225483617 cites W3208639677 @default.
• W4225483617 cites W3215658168 @default.
• W4225483617 doi "https://doi.org/10.1371/journal.pone.0267102" @default.
• W4225483617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35446889" @default.
• W4225483617 hasPublicationYear "2022" @default.
• W4225483617 type Work @default.
• W4225483617 citedByCount "12" @default.
• W4225483617 countsByYear W42254836172022 @default.
• W4225483617 countsByYear W42254836172023 @default.
• W4225483617 crossrefType "journal-article" @default.
• W4225483617 hasAuthorship W4225483617A5002287966 @default.
• W4225483617 hasAuthorship W4225483617A5006031285 @default.
• W4225483617 hasAuthorship W4225483617A5006890215 @default.
• W4225483617 hasAuthorship W4225483617A5007003740 @default.
• W4225483617 hasAuthorship W4225483617A5026707377 @default.
• W4225483617 hasAuthorship W4225483617A5027042022 @default.
• W4225483617 hasAuthorship W4225483617A5027750644 @default.
• W4225483617 hasAuthorship W4225483617A5028987829 @default.
• W4225483617 hasAuthorship W4225483617A5035447212 @default.
• W4225483617 hasAuthorship W4225483617A5042228931 @default.
• W4225483617 hasAuthorship W4225483617A5042282160 @default.
• W4225483617 hasAuthorship W4225483617A5051156541 @default.

• next